HugoScore hugoscore.org

Full review

Kin Health CAIHL draft report

Evidence-linked HugoScore draft report for a health AI tool that affects patients.

Kin Health: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Kin supports patient-started visit recording, preparation questions, and optional sharing. Input ownership is clearer than generated-output ownership, and the terms place limits on service evaluation alongside broad content permissions.

Scope and agency posture

Kin Health Technologies' patient-selected visit recording, summaries, preparation, and Care Circle use. Vendor-hosted consumer service, independent of a particular provider. Pet-care marketing is outside this human-patient finding.

Posture: Potentially agency-expanding, with output-rights qualifications.

Axis: 79/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

  • The homepage describes patient-started recording, preparation questions, and shareable summaries. The trust page says sessions are user-initiated, sharing is optional, and summaries can be deleted.
  • The terms, sections 3–5, recognize input ownership and grant Care Circle members use rights. They also license content and outputs for broad business purposes and restrict benchmarking or use to Kin's detriment. Output ownership is not granted as clearly as input ownership.

Patient authority

Inference from the documented workflow: Starting a recording and choosing recipients supports patient authorship. The documented Care Circle license enables action beyond passive viewing. Neither control establishes unrestricted independent evaluation of the operator.

Critical capacity

Editorial assessment: A reusable visit account and patient-written questions can help identify omissions and seek clarification. The baseline's 'own record' language should distinguish ownership of inputs from generated outputs.

Informed control

Editorial assessment: Simple privacy promises do not fully communicate the broad content license and evaluation restriction. These constrain the conditions of reliance, without establishing misuse or a prohibition on ordinary criticism.

Assessment and limits

Keep the positive patient-side workflow finding, but add the concrete output-rights and scrutiny limitations. The business model alone is not grounds for a penalty.

Confidence: Medium for documentation.

Remaining uncertainty: Export and correction mechanics, generated-output ownership, actual limits on independent evaluation, and data-license implementation.

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

  • Reviewer/model: OpenAI Codex / GPT-6.
  • Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
  • Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
  • Earlier review: 2026-06-08. Historical assessment. Earlier claims are not automatically reverified by this publication.